• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro" [Int. J. Pharm. 553 (2018) 201-209].

作者信息

Tan Tao, Wang Yuqi, Wang Hong, Cao Haiqiang, Wang Zhiwan, Wang Jing, Li Jie, Li Yaping, Zhang Zhiwen, Wang Siling

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.

State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Int J Pharm. 2020 Feb 25;576:119054. doi: 10.1016/j.ijpharm.2020.119054. Epub 2020 Jan 22.

DOI:10.1016/j.ijpharm.2020.119054
PMID:31982211
Abstract
摘要

相似文献

1
Corrigendum to "Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro" [Int. J. Pharm. 553 (2018) 201-209].《载有美登素的脱铁铁蛋白纳米笼在体外能有效根除癌症干细胞》的勘误[《国际药学杂志》553 (2018) 201 - 209]
Int J Pharm. 2020 Feb 25;576:119054. doi: 10.1016/j.ijpharm.2020.119054. Epub 2020 Jan 22.
2
Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro.载柔红霉素的去铁铁蛋白纳米笼在体外有效清除肿瘤干细胞样细胞。
Int J Pharm. 2018 Dec 20;553(1-2):201-209. doi: 10.1016/j.ijpharm.2018.10.038. Epub 2018 Oct 16.
3
Corrigendum to "Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy" [Int. J. Pharm. 605 (2021) 120805].对“具有超高载药量的自组装前药纳米递送增强化疗疗效”[《国际药学杂志》605 (2021) 120805]的勘误
Int J Pharm. 2023 Aug 25;643:123290. doi: 10.1016/j.ijpharm.2023.123290. Epub 2023 Aug 12.
4
Corrigendum to 'A surfactant-like chemotherapeutic agent as a nanocarrier for delivering photosensitizers against cancer: A facile drug-delivering-drug strategy' [Int. J. Pharm. 562 (2019) 313-320].《一种类似表面活性剂的化疗药物作为递送光敏剂抗癌的纳米载体：一种简便的药物递送药物策略》的勘误 [《国际药学杂志》562 (2019) 313 - 320]
Int J Pharm. 2019 Aug 15;567:118463. doi: 10.1016/j.ijpharm.2019.118463. Epub 2019 Jun 27.
5
Corrigendum to "Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity" [Int. J. Pharm. 590 (2020) 119926].《制造靶向乳腺癌的药物共载脂质体制剂：制备方法对脂质体特性和体外毒性的影响》的勘误 [《国际药学杂志》590 (2020) 119926]
Int J Pharm. 2021 Apr 15;599:120440. doi: 10.1016/j.ijpharm.2021.120440. Epub 2021 Mar 14.
6
Corrigendum to "In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis" [Int. J. Pharm. 535 (2018) 113-119].《甲状旁腺激素PTH 1-34鼻内喷雾剂治疗骨质疏松症的体外和临床前评估》勘误 [《国际药学杂志》535 (2018) 113-119]
Int J Pharm. 2018 Aug 25;547(1-2):667. doi: 10.1016/j.ijpharm.2018.06.045. Epub 2018 Jul 5.
7
Corrigendum to "Identification of critical formulation parameters affecting the in vitro release, permeation, and rheological properties of the acyclovir topical cream" [Int. J. Pharm. 590 (2020) 119914].《关于“确定影响阿昔洛韦外用乳膏体外释放、渗透及流变学性质的关键制剂参数”的勘误》[《国际药学杂志》590 (2020) 119914]
Int J Pharm. 2021 Jul 15;604:120787. doi: 10.1016/j.ijpharm.2021.120787. Epub 2021 Jun 16.
8
Corrigendum to "Development of silymarin topical formulation: In vitro and ex vivo dermal kinetics of silymarin" [Int. J. Pharm. 63 (2023) 122431].《水飞蓟素局部制剂的研发：水飞蓟素的体外和离体皮肤动力学》[《国际药学杂志》63 (2023) 122431]勘误
Int J Pharm. 2023 Mar 25;635:122590. doi: 10.1016/j.ijpharm.2023.122590. Epub 2023 Mar 6.
9
Corrigendum to "In vitro and in vivo characterization of Miconazole Nitrate loaded transethosomes for the treatment of Cutaneous Candidiasis" [Int. J. Pharm. 647 (2023) 123563].《硝酸咪康唑负载转质体治疗皮肤念珠菌病的体外和体内特性研究》的勘误[《国际药学杂志》647 (2023) 123563]
Int J Pharm. 2024 Jan 5;649:123631. doi: 10.1016/j.ijpharm.2023.123631. Epub 2023 Dec 3.
10
Corrigendum to "Lipid-liquid crystals for 2 months controlled risperidone release: In-vitro evaluation and pharmacokinetics in rabbits" [Int. J. Pharm. 618 (2022) 121649].《用于利培酮2个月控释的脂质液晶：兔体内体外评价及药代动力学》的勘误[《国际药学杂志》618 (2022) 121649]
Int J Pharm. 2023 Mar 25;635:122673. doi: 10.1016/j.ijpharm.2023.122673. Epub 2023 Feb 2.